Literature DB >> 11599297

Neurosteroids: beginning of the story.

E E Baulieu1, P Robel, M Schumacher.   

Abstract

Neurosteroids are synthetisized in the central and the peripheral nervous system, in glial cells, and also in neurons, from cholesterol or steroidal precursors imported from peripheral sources. They include 3 beta-hydroxy-delta 5-compounds, such as pregnenolone (PREG) and dehydroepiandrosterone, their sulfate esters, and compounds known as reduced metabolites of steroid hormones, such as the tetrahydroderivative of progesterone 3 alpha-hydroxy-5 alpha-pregnan-20-one. These neurosteroids can act as modulators of neurotransmitter receptors, such as GABAA, NMDA, and sigma 1 receptors. Progesterone itself is also a neurosteroid, and a progesterone receptor has been detected in peripheral and central glial cells. At different sites in the brain, neurosteroid concentrations vary according to environmental and behavioral circumstances, such as stress, sex recognition, or aggressiveness. A physiological function of neurosteroids in the central nervous system is strongly suggested by the role of hippocampal PREGS with respect to memory performance, observed in aging rats. In the peripheral nervous system, a role for PROG synthesized in Schwann cells has been demonstrated in remyelination after cryolesion of the sciatic nerve in vivo and in cultures of dorsal root ganglia. A new mechanism of PREG action discovered in the brain involves specific steroid binding to microtubule associated protein and increased tubulin polymerization for assembling microtubules. It may be important to study the effects of abnormal neurosteroid concentration/metabolism in view of the possible treatment of functional and trophic disturbances of the nervous system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11599297     DOI: 10.1016/s0074-7742(01)46057-0

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  83 in total

1.  Anxiolytic drug targets: beyond the usual suspects.

Authors:  Joshua A Gordon
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

2.  Complex actions of estradiol-3-sulfate in late gestation fetal brain.

Authors:  Jared Winikor; Christine Schlaerth; Maria Belen Rabaglino; Roderick Cousins; Monique Sutherland; Charles E Wood
Journal:  Reprod Sci       Date:  2011-01-27       Impact factor: 3.060

Review 3.  Myelin disorders: Causes and perspectives of Charcot-Marie-Tooth neuropathy.

Authors:  Gerd Meyer zu Hörste; Thomas Prukop; Klaus-Armin Nave; Michael W Sereda
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 4.  Neuroactive steroids and anxiety disorders.

Authors:  Jean-Michel Le Mellédo; Glen B Baker
Journal:  J Psychiatry Neurosci       Date:  2002-05       Impact factor: 6.186

5.  Distribution and quantitative detection of GABAA receptor in Carassius auratus gibelio.

Authors:  Jiming Ruan; Kun Hu; Haixin Zhang; Yi Wang; Ailing Zhou; Yini Zhao; Xianle Yang
Journal:  Fish Physiol Biochem       Date:  2014-04-01       Impact factor: 2.794

6.  Allopregnanolone increases the number of dopaminergic neurons in substantia nigra of a triple transgenic mouse model of Alzheimer's disease.

Authors:  Chenyou Sun; Xiaoming Ou; Jerry M Farley; Craig Stockmeier; Steven Bigler; Roberta Diaz Brinton; Jun Ming Wang
Journal:  Curr Alzheimer Res       Date:  2012-05       Impact factor: 3.498

7.  Gender and age differences in expression of GABAA receptor subunits in rat somatosensory thalamus and cortex in an absence epilepsy model.

Authors:  Huifang Li; John R Huguenard; Robert S Fisher
Journal:  Neurobiol Dis       Date:  2007-01-05       Impact factor: 5.996

8.  De novo synthesis of steroids and oxysterols in adipocytes.

Authors:  Jiehan Li; Edward Daly; Enrico Campioli; Martin Wabitsch; Vassilios Papadopoulos
Journal:  J Biol Chem       Date:  2013-11-26       Impact factor: 5.157

Review 9.  Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders.

Authors:  Teruo Hayashi; Tsung-Ping Su
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 10.  MAM: more than just a housekeeper.

Authors:  Teruo Hayashi; Rosario Rizzuto; Gyorgy Hajnoczky; Tsung-Ping Su
Journal:  Trends Cell Biol       Date:  2009-01-12       Impact factor: 20.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.